封面
市場調查報告書
商品編碼
1586130

心血管吻合裝置市場:依產品類型、應用分類 - 全球預測 2025-2030

Cardiovascular Anastomosis Devices Market by Product Type (Automatic, Manual), End-Use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心血管吻合器械市場價值為17.9億美元,預計到2024年將達到19.7億美元,複合年成長率為10.63%,預計到2030年將達到36.3億美元。

心血管吻合器是外科手術中連結血管、促進血流、促進癒合的重要工具。這些儀器對於血管成形術、搭橋手術和器官移植等手術至關重要。由於人口老化、久坐的生活方式和不健康的飲食,全球心血管疾病的盛行率不斷增加,因此對這些設備的需求越來越大。其應用涵蓋大量最終用戶,包括醫院、專科診所和門診手術中心,反映出進行心血管手術的地點廣泛。市場成長主要是由微創手術需求的增加、吻合裝置的技術進步以及政府的支持政策所推動的。主要商機位於新興市場,這些市場的醫療保健支出不斷增加,對先進醫療保健基礎設施的需求尚未滿足。為了利用這些機會,公司應該透過研究和開發來擴大產品系列,並專注於滿足這些地區需求的經濟高效的設備。然而,嚴格的監管核准、手術高成本以及手術期間潛在的併發症等挑戰可能會阻礙市場成長。生物可吸收設備的開發、吻合過程的自動化以及人工智慧的整合等領域的創新已經成熟,以提高結果的準確性和可預測性。個人化醫療也有潛力,可以客製化設備以滿足個別患者的需求。市場競爭非常激烈,越來越多的新參與企業專注於利基創新,而現有公司的影響力也越來越大。透過了解這些動態並採取策略夥伴關係、研發投資以及以患者為中心的方法,公司可以克服挑戰並利用心血管吻合設備市場的成長潛力。了解監管環境並與醫療保健提供者建立關係對於長期成功也至關重要。

主要市場統計
基準年[2023] 17.9億美元
預測年份 [2024] 19.7億美元
預測年份 [2030] 36.3億美元
複合年成長率(%) 10.63%

市場動態:快速發展的心血管吻合裝置市場的關鍵市場洞察

供需的動態交互作用正在改變心血管吻合裝置市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,並了解消費行為及其對製造成本的影響,並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球心臟疾病盛行率不斷上升
    • 由於吸煙、菸草和酒精消費的增加,久坐的生活方式增加
    • 全球外科手術數量增加
  • 市場限制因素
    • 治療費用高且缺乏先進的醫療基礎設施
  • 市場機會
    • 心血管吻合器技術發展進展
    • 政府措施和醫療機構的潛在資金
  • 市場挑戰
    • 對吻合併發症的擔憂

波特五力:駕馭心血管吻合器械市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解心血管吻合器械市場的外部影響

外部宏觀環境因素在塑造心血管吻合器材市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心血管吻合器材市場競爭格局

對心血管吻合裝置市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心血管吻合裝置市場供應商的績效評估

FPNV 定位矩陣是評估心血管吻合設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議,以規劃心血管吻合器材市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對心血管吻合裝置市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全世界心臟病的發生率正在增加。
      • 隨著吸菸、菸草和酒精消費的增加,久坐的生活方式也增加
      • 全球手術數量不斷增加
    • 抑制因素
      • 治療費用高且缺乏先進的醫療基礎設施
    • 機會
      • 心血管吻合器技術發展進展
      • 政府措施和醫療機構的潛在資金
    • 任務
      • 對吻合併發症的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心血管吻合裝置市場:依產品類型

  • 自動的
  • 手動的

第7章心血管吻合裝置市場:依最終用途

  • 門診手術中心
  • 醫院
  • 專科診所

第8章北美和南美心血管吻合器材市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太心血管吻合器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲心血管吻合器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Applied Medical Resources Corporation
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Biosintex
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Peters Surgical
Product Code: MRR-8C74ADFBF9A7

The Cardiovascular Anastomosis Devices Market was valued at USD 1.79 billion in 2023, expected to reach USD 1.97 billion in 2024, and is projected to grow at a CAGR of 10.63%, to USD 3.63 billion by 2030.

Cardiovascular anastomosis devices are critical tools used in surgical procedures to join blood vessels, facilitating blood flow and promoting healing. These devices are integral in procedures such as angioplasty, bypass surgeries, and organ transplantation. The necessity of these devices stems from the rising prevalence of cardiovascular diseases globally, driven by aging populations, sedentary lifestyles, and unhealthy diets. Their application spans numerous end-users including hospitals, specialty clinics, and ambulatory surgical centers, reflecting the broad scope of where cardiovascular surgeries are performed. Market growth is significantly influenced by the increasing demand for minimally invasive surgical procedures, technological advancements in anastomosis devices, and supportive government policies. Key opportunities lie in emerging markets with increasing healthcare expenditure and the unmet need for advanced healthcare infrastructure. To capitalize on these opportunities, companies should focus on expanding product portfolios through research and development, emphasizing cost-effective and efficient devices that cater to these regions. However, challenges such as stringent regulatory approvals, high cost of surgical procedures, and potential complications during surgeries may hinder market growth. Innovation is ripe in areas like the development of bioresorbable devices, automation in anastomosis processes, and integration of AI for enhanced precision and outcome predictability. There's also potential in personalized medicine, where device customization can cater to individual patient needs. The market is competitive with a significant presence of established players, alongside growing participation from new entrants focusing on niche innovations. By understanding these dynamics and focusing on strategic partnerships, investments in R&D, and adopting a patient-centric approach, companies can navigate the challenges and harness the growth potentials of the cardiovascular anastomosis devices market. Understanding the regulatory landscape and fostering relationships with healthcare providers are also vital for long-term success.

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 1.97 billion
Forecast Year [2030] USD 3.63 billion
CAGR (%) 10.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Anastomosis Devices Market

The Cardiovascular Anastomosis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiac diseases globally
    • Rising sedentary lifestyle along with increasing smoking, tobacco, and alcohol consumption
    • Growing number of surgical procedures globally
  • Market Restraints
    • Highly expensive treatments and lack of advanced healthcare infrastructure
  • Market Opportunities
    • Advancements in technological developments in the cardiovascular anastomosis devices
    • Government initiatives and availability of funding for healthcare facilities
  • Market Challenges
    • Concerns related to anastomosis complications

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Anastomosis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Anastomosis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Anastomosis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Anastomosis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Anastomosis Devices Market

A detailed market share analysis in the Cardiovascular Anastomosis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Anastomosis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Anastomosis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Anastomosis Devices Market

A strategic analysis of the Cardiovascular Anastomosis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Anastomosis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Applied Medical Resources Corporation, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Biosintex, Boston Scientific Corporation, CryoLife, Inc., Edwards Lifesciences Corporation, Getinge AB, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., and Peters Surgical.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Anastomosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Automatic and Manual.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiac diseases globally
      • 5.1.1.2. Rising sedentary lifestyle along with increasing smoking, tobacco, and alcohol consumption
      • 5.1.1.3. Growing number of surgical procedures globally
    • 5.1.2. Restraints
      • 5.1.2.1. Highly expensive treatments and lack of advanced healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technological developments in the cardiovascular anastomosis devices
      • 5.1.3.2. Government initiatives and availability of funding for healthcare facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to anastomosis complications
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Anastomosis Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Automatic
  • 6.3. Manual

7. Cardiovascular Anastomosis Devices Market, by End-Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Cardiovascular Anastomosis Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiovascular Anastomosis Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiovascular Anastomosis Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Applied Medical Resources Corporation
  • 3. B. Braun Melsungen AG
  • 4. Baxter International, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Biosintex
  • 7. Boston Scientific Corporation
  • 8. CryoLife, Inc.
  • 9. Edwards Lifesciences Corporation
  • 10. Getinge AB
  • 11. Intuitive Surgical, Inc.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Medtronic PLC
  • 14. Meril Life Sciences Pvt. Ltd.
  • 15. Peters Surgical

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023